Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Cell Mol Pharmacol 2022, Vol 6(4)Vol 6(4)
  • DOI: 10.4172/jcmp.1000126

Case report of castration-resistant prostate cancer with metastasis to the external auditory canal

Naoki Akagi*
Department of Urology, Takarazuka City Hospital, Japan
*Corresponding Author : Naoki Akagi, Department of Urology, Takarazuka City Hospital, Japan, Email: naoakivuyi@gmail.com

Received Date: Aug 04, 2022 / Published Date: Aug 29, 2022

Abstract

A case of castration-resistant prostate cancer metastasis to an external auditory canal is described. Prostate cancer (cT3aN1M1b GS5+5) was discovered in a 68-year-old man. Despite the fact that abiraterone, docetaxel, and cabazitaxel were administered and PSA levels were reduced, liver metastasis developed [1-15].Hearing loss was also noted in the left ear, and the patient was referred to an otolaryngologist for an examination, which revealed a neoplastic lesion in the external auditory canal. The results of the biopsy revealed that the patient had adenocarcinoma. Details of a rare case of prostate cancer metastasis to an external auditory canal are presented here.

Citation: Akagi N (2022) Case Report of Castration-Resistant Prostate Cancer with Metastasis to the External Auditory Canal. J Cell Mol Pharmacol 6: 126. Doi: 10.4172/jcmp.1000126

Copyright: © 2022 Akagi N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top